Literature DB >> 31435829

Early detection of cognitive impairment in Parkinson's disease with the use of the Wisconsin Card Sorting Test: correlations with Montreal Cognitive Assessment and smell identification test.

Fumihito Yoshii1,2, Hiroe Onaka3, Saori Kohara3, Masafuchi Ryo4, Wakoh Takahashi4, Shigeru Nogawa5.   

Abstract

Cognitive function is often impaired in early Parkinson's disease (PD). The Wisconsin Card Sorting Test (WCST) is a neuropsychological test of "set-shifting" ability. To see whether WCST is useful for detecting early changes of cognitive function in PD, we examined the correlations of WCST with the Montreal Cognitive Assessment (MoCA) and the Odor Stick Identification Test (OSIT). Subjects were 48 PD patients (age 66 ± 10 years; Hoehn & Yahr stage 2.3 ± 0.8; mean duration 3.1 ± 2.5 years). WCST sub-scores for categories achieved (CA), perseverative errors of Nelson type (PEN), and difficulties of maintaining set (DMS) were evaluated. MoCA-J (Japanese version) and OSIT-J (Japanese version) were done in that order, followed by the WCST. In PD patients, CA was 2.2 ± 2.0, PEN was 7.0 ± 6.4, and DMS was 2.3 ± 2.0, and all were worse than those of age-matched normal subjects. MoCA-J scores significantly correlated with PEN. OSIT-J scores were also significantly correlated with CA and DMS. As MoCA-J and OSIT-J show high sensitivity and specificity for detecting mild cognitive impairment in PD, WCST may also be a useful supplementary diagnostic tool for early and mild cognitive impairment in PD patients.

Entities:  

Keywords:  Cognitive impairment; DAT-SPECT imaging; Montreal Cognitive Assessment (MoCA); Odor Stick Identification Test (OSIT); Parkinson’s disease; Wisconsin Card Sorting Test (WCST)

Mesh:

Year:  2019        PMID: 31435829     DOI: 10.1007/s00702-019-02066-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  38 in total

1.  A recommended scale for cognitive screening in clinical trials of Parkinson's disease.

Authors:  Kelvin L Chou; Melissa M Amick; Jason Brandt; Richard Camicioli; Karen Frei; Darren Gitelman; Jennifer Goldman; John Growdon; Howard I Hurtig; Bonnie Levin; Irene Litvan; Laura Marsh; Tanya Simuni; Alexander I Tröster; Ergun Y Uc
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

Review 2.  MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Authors:  Irene Litvan; Dag Aarsland; Charles H Adler; Jennifer G Goldman; Jaime Kulisevsky; Brit Mollenhauer; Maria C Rodriguez-Oroz; Alexander I Tröster; Daniel Weintraub
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

Review 3.  Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.

Authors:  Per Svenningsson; Eric Westman; Clive Ballard; Dag Aarsland
Journal:  Lancet Neurol       Date:  2012-08       Impact factor: 44.182

4.  Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.

Authors:  Daniel Weintraub; Tanya Simuni; Chelsea Caspell-Garcia; Christopher Coffey; Shirley Lasch; Andrew Siderowf; Dag Aarsland; Paolo Barone; David Burn; Lama M Chahine; Jamie Eberling; Alberto J Espay; Eric D Foster; James B Leverenz; Irene Litvan; Irene Richard; Matthew D Troyer; Keith A Hawkins
Journal:  Mov Disord       Date:  2015-03-04       Impact factor: 10.338

5.  Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.

Authors:  S Hoops; S Nazem; A D Siderowf; J E Duda; S X Xie; M B Stern; D Weintraub
Journal:  Neurology       Date:  2009-11-24       Impact factor: 9.910

6.  Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.

Authors:  Nagaendran Kandiah; Angeline Zhang; Alvin Rae Cenina; Wing Lok Au; Nivedita Nadkarni; Louis Cs Tan
Journal:  Parkinsonism Relat Disord       Date:  2014-08-14       Impact factor: 4.891

7.  People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance.

Authors:  Daniel J Burdick; Brenna Cholerton; G S Watson; Andrew Siderowf; John Q Trojanowski; Daniel Weintraub; Beate Ritz; Shannon L Rhodes; Renecca Rausch; Stewart A Factor; Cathy Wood-Siverio; Joseph F Quinn; Kathryn A Chung; Sindhu Srivatsal; Karen L Edwards; Thomas J Montine; Cyrus P Zabetian; James B Leverenz
Journal:  Mov Disord       Date:  2014-07-29       Impact factor: 10.338

Review 8.  Global scales for cognitive screening in Parkinson's disease: Critique and recommendations.

Authors:  Matej Skorvanek; Jennifer G Goldman; Marjan Jahanshahi; Connie Marras; Irena Rektorova; Ben Schmand; Erik van Duijn; Christopher G Goetz; Daniel Weintraub; Glenn T Stebbins; Pablo Martinez-Martin
Journal:  Mov Disord       Date:  2017-11-23       Impact factor: 10.338

9.  Wisconsin Card Sorting Test scores and clinical and sociodemographic correlates in Schizophrenia: multiple logistic regression analysis.

Authors:  Masahiro Banno; Takayoshi Koide; Branko Aleksic; Takashi Okada; Tsutomu Kikuchi; Kunihiro Kohmura; Yasunori Adachi; Naoko Kawano; Tetsuya Iidaka; Norio Ozaki
Journal:  BMJ Open       Date:  2012-11-06       Impact factor: 2.692

10.  Japanese multicenter database of healthy controls for [123I]FP-CIT SPECT.

Authors:  Hiroshi Matsuda; Miho Murata; Yohei Mukai; Kazuya Sako; Hidetoshi Ono; Hiroshi Toyama; Yoshitaka Inui; Yasuyuki Taki; Hideo Shimomura; Hiroshi Nagayama; Amane Tateno; Kenjiro Ono; Hidetomo Murakami; Atsushi Kono; Shigeki Hirano; Satoshi Kuwabara; Norihide Maikusa; Masayo Ogawa; Etsuko Imabayashi; Noriko Sato; Harumasa Takano; Jun Hatazawa; Ryosuke Takahashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02-24       Impact factor: 9.236

View more
  2 in total

1.  Olfaction and Executive Cognitive Performance: A Systematic Review.

Authors:  Vasudeva Murthy Challakere Ramaswamy; Peter William Schofield
Journal:  Front Psychol       Date:  2022-05-09

2.  Olfactory capacity in anorexia nervosa: correlations with set-shifting ability.

Authors:  Anna Karavia; Fotini Kapsali; Fragiskos Gonidakis; Arta Koliou; Evdoxia Tsigkaropoulou; Charalabos Papageorgiou; Ioannis Michopoulos
Journal:  Eat Weight Disord       Date:  2021-04-15       Impact factor: 4.652

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.